ClinConnect ClinConnect Logo
Search / Trial NCT04064177

Non-invasive Continuous Cardiac Output Monitoring in Preterm Infants Study

Launched by IMPERIAL COLLEGE HEALTHCARE NHS TRUST · Aug 20, 2019

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Blood Pressure

ClinConnect Summary

The Non-invasive Continuous Cardiac Output Monitoring in Preterm Infants Study is looking at how we can safely and effectively monitor the heart function in newborn babies, especially those born early (preterm). The researchers want to see if a non-invasive method—meaning it doesn’t involve needles or surgery—can continuously measure the amount of blood the heart pumps out. They will also examine how this measurement changes when infants receive extra fluids or medications that help the heart work better.

To participate in this study, infants must be healthy term babies in the hospital within their first 72 hours or preterm babies admitted to the neonatal unit. Parents will need to give written consent for their babies to be part of the study. Unfortunately, babies with serious birth defects or those who are older than 12 hours, as well as those with very delicate skin, cannot participate. If enrolled, families can expect regular monitoring of their baby’s heart function without any invasive procedures, helping doctors better understand how to care for these vulnerable infants.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Healthy term infants in postnatal ward (within the first 72 hours of age)
  • Term and Preterm infants (including those with FGR) admitted to the neonatal unit
  • Written informed parental consent (prospective for postnatal ward and retrospective for babies admitted to the neonatal units)
  • Exclusion Criteria:
  • Antenatal or postnatal diagnosis of severe congenital anomaly
  • Infants with no realistic chance of survival
  • Infants who are \>12 hours of age
  • Infants with fragile skin not permitting skin probe placement

About Imperial College Healthcare Nhs Trust

Imperial College Healthcare NHS Trust is a leading healthcare provider in London, renowned for its commitment to delivering high-quality patient care and advancing medical research. As an integral part of the NHS, the Trust encompasses a range of specialized services and facilities, including multiple hospitals and outpatient centers, where it fosters a collaborative environment for clinical trials. With a focus on innovation and excellence, Imperial College Healthcare NHS Trust supports a diverse portfolio of clinical research initiatives aimed at translating scientific discoveries into effective treatments and improving health outcomes for patients. Its partnership with Imperial College London enhances its capabilities in cutting-edge research, making it a pivotal institution in the landscape of healthcare and clinical trials.

Locations

London, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Jayanta Banerjee

Principal Investigator

Neonatal consultant

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials